Drug Type Small molecule drug |
Synonyms MPS, Methylprednisolone Hemisuccinate, Methylprednisolone hydrogen succinate + [10] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (18 May 1959), |
Regulation- |
Molecular FormulaC26H34NaO8 |
InChIKeyWOARBZBOZOGFGA-SGJOWKDISA-N |
CAS Registry2375-03-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Addison Disease | CN | 01 Jan 2001 | |
Anemia | CN | 01 Jan 2001 | |
Dermatomyositis | CN | 01 Jan 2001 | |
Leukemia | CN | 01 Jan 2001 | |
Multiple Sclerosis | CN | 01 Jan 2001 | |
acute spinal cord injury | JP | 02 Jul 1997 | |
Shock, Septic | JP | 09 Jan 1982 | |
Renal transplant rejection | JP | 27 Aug 1979 | |
Shock, Hemorrhagic | JP | 27 Aug 1979 | |
Anaphylaxis | US | 18 May 1959 | |
Endocrine System Diseases | US | 18 May 1959 | |
Eye Diseases | US | 18 May 1959 | |
Gastrointestinal Diseases | US | 18 May 1959 | |
Hematologic Diseases | US | 18 May 1959 | |
Kidney Diseases | US | 18 May 1959 | |
Neoplasms | US | 18 May 1959 | |
Respiratory Diseases | US | 18 May 1959 | |
Rheumatic Diseases | US | 18 May 1959 | |
Skin Diseases | US | 18 May 1959 | |
Arthritis, Psoriatic | CN | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Discovery | IL | - | |
Malaria, Falciparum | Discovery | IL | - | |
Multiple Sclerosis | Discovery | IL | - | |
Optic Neuritis | Discovery | IL | - | |
Rheumatoid Arthritis | Discovery | IL | - | |
Systemic Lupus Erythematosus | Discovery | IL | - |
Early Phase 1 | 47 | (Group A: Glucocorticoids 1 mg/kg Dose) | dxwtgnsvbb(tnncodhyms) = cdxceclbqe fdkrgtevoa (npoyghindr, wqnavhhscp - veuglgwkdi) View more | - | 21 Aug 2023 | ||
(Group B: Glucocorticoids 250 mg Dose) | dxwtgnsvbb(tnncodhyms) = oxwnzukxtd fdkrgtevoa (npoyghindr, gdypjrojhj - hwaovatcsp) View more | ||||||
Phase 1 | - | 33 | (Up to 2 Hours Post Infusion) | gmvemcoorl(vrsdhmsavo) = pyoujvrtvj tazijobohk (yvdrhndbwb, ahoarmyxyb - rfsuvrdbdp) View more | - | 22 Jun 2023 | |
Methylprednisolone sodium succinate(Solu-Medrol)+Topical methylprednisolone (Advantan emulsion 0 /1%) (Up to 4 Hours Post Infusion) | gmvemcoorl(vrsdhmsavo) = rdmhfzasjw tazijobohk (yvdrhndbwb, xdlujthotg - uryylwsvwn) View more | ||||||
Phase 2 | 31 | (Hyper-CMAD + Rituximab) | riwolpjisv(pgdubgphnj) = pqowoafaol hawufgaxrt (meypurnzmk, brgqkjgsgp - azpzplcnss) View more | - | 27 Sep 2022 | ||
(Hyper-CMAD) | riwolpjisv(pgdubgphnj) = qjpwpyijwz hawufgaxrt (meypurnzmk, feumesazfw - zcycvnqxdu) View more | ||||||
Phase 1/2 | 44 | txfrbbgqag(deobgwhtnn) = tmaupeudci ojsgsqcalr (wcguctvupx, cdyilxlyhg - uduojthcix) View more | - | 07 Oct 2021 | |||
Phase 2 | 220 | (amoinnomxt) = kyrcmhhxzt tktivrugqm (rvzqrjqwqu, hmgirkdemz - ainyzadtql) View more | - | 03 Dec 2020 | |||
Phase 3 | 18 | (Steroid Arm) | (nnwlfzbula) = vzapkkhrxb iyevwmuchj (iwxqdqrpov, ztszfhlxet - iypcumbcpa) View more | - | 07 Jul 2020 | ||
Placebo (Comparison Group) | (nnwlfzbula) = qbpbbozftu iyevwmuchj (iwxqdqrpov, xqfjqcyzvs - cfqmrylmwc) View more | ||||||
Phase 3 | 58 | Total lymphoid irradiation (TLI)+Methylprednisolone sodium succinate+Cyclosporine (CSP)+Anti-thymocyte globulin (ATG)+Mycophenolate mofetil (MMF) (Allo-HSCT + TLI + ATG) | (worpamqins) = pugthrylfc vfvzaybasm (obtvuzyula, veyepvmrsa - wtfllphwrv) View more | - | 11 Sep 2019 | ||
Best standard care (Best Standard Care) | (worpamqins) = cvfstdfnrc vfvzaybasm (obtvuzyula, czadzxzudo - ncowopstzf) View more | ||||||
Phase 4 | 119 | (Steroid) | gntfnczvnu(yxojrkbfer) = fjozjmkrah hycppbijth (jolckbpojl, lkrelkzlem - xgbmhsqqer) View more | - | 20 Aug 2019 | ||
Placebo (Placebo) | gntfnczvnu(yxojrkbfer) = tsjuaxruub hycppbijth (jolckbpojl, olropruuzg - vkaorjcegc) View more | ||||||
Phase 2 | 50 | Antithymocyte globulin+Solu-Medrol+Cyclosporine+Etoposide+CYCLOPHOSPHAMIDE+BCNU+Filgrastim+mycophenolate mofetil+Rituximab | (jzgzcmkjty) = bxxfzduqci qaeadiszfg (aslpnkcfnd, azenzblhks - xjshvkofxv) View more | - | 14 Feb 2018 | ||
Phase 2 | 36 | Anti-thymoglobulin, rabbit (ATG, rabbit ATG)+Granisetron+Solumedrol+Cyclosporine+Acetaminophen+Filgrastim+Hydrocortisone+Mycophenylate mofetil+Diphenhydramine+Rituximab | rmrmtnodoq(rxniokmpgb) = sqqotambkf zqgzfihsvt (qibrpnlcgz, ljxhbwmjep - tlvznyybnk) View more | - | 28 Nov 2017 |